LUMIRABIO 药光生物
EN
English简体中文

Semaglutide Tirzepatide Retatrutide

From Molecules to Kilogram Scale.Focused on Three Core Peptide APIs.

LUMIRABIO supports development, synthesis, purification, analysis, scale-up, and peptide API raw material supply for Semaglutide, Tirzepatide, and investigational Retatrutide. Form, specification, site, batch evidence, and market eligibility remain project-specific.

Request a technical dossier review

Institutional B2B requests only. The team reviews organization, intended use, market and disclosure rights. Submission is not qualification, a supply commitment or automatic CoA access. Retatrutide requests are limited to qualified institutional research and development review.

Do not include patient, personal-use, medical or confidential project information.

Documents are shared only after qualification and disclosure approval.

Explore core products
LUMIRABIO peptide API packaging and powder in a bright analytical laboratory
Metabolic peptide focusThree molecules, reviewed separately
Supplied purity ≥99%Guaranteed specification; batch result documented in the CoA
200 kg/month capacityAggregate capacity; allocation confirmed per inquiry
U.S. warehouse coordinationLos Angeles and New Jersey pathways

A Focused Metabolic Peptide API Portfolio

Molecular identity comes first. Raw material supply scope, specification, documentation, and availability are confirmed by inquiry, project, and batch.

Semaglutide primary-sequence identity schematic showing Aib and C18 lipidation features

Semaglutide

Peptide APIScope confirmed per inquiry

Molecular formulaC187H291N45O59

CAS910463-68-2

Open product dossier
Tirzepatide primary-sequence identity schematic showing two Aib residues and C20 lipidation features

Tirzepatide

Peptide APIScope confirmed per inquiry

Molecular formulaC225H348N48O68

CAS2023788-19-2

Open product dossier
Retatrutide research-stage primary-sequence identity schematic showing engineered residues and C20 lipidation features

Retatrutide

Investigational peptideScope confirmed per inquiry

Molecular formulaC221H342N46O68

CASConfirm exact form

Investigational. Exact form and target-market eligibility require review.Open product dossier

Why Choose LUMIRABIO

Four coordinated strengths for one focused metabolic peptide field.

A focused molecule scope, analytical review, scalable manufacturing, and two U.S. warehouse pathways support clearer sourcing decisions.

Field focus

Metabolic peptide API specialization

The current scope covers Semaglutide, Tirzepatide, and investigational Retatrutide, with each molecule and status boundary reviewed separately.

Supply specification

Supplied purity ≥99%

LUMIRABIO supplies peptide APIs to a purity specification of at least 99%, with each batch result documented in the applicable CoA.

Scalable manufacturing

Milligram-to-kilogram pathways

Aggregate factory capacity is 200 kg/month; product, site, form, and schedule remain inquiry-specific.

Regional coordination

U.S. warehouse support

Los Angeles and New Jersey may support eligible inventory and regional dispatch after product, local availability, release, and batch confirmation.

Representative peptide manufacturing environment

Manufacturing capabilities

Manufacturing Capability.
Clear Project Boundaries.

GMP-standard workshop discussions support route assessment, purification, analytical alignment, and scale planning. The factory has an aggregate peptide API capacity of 200 kg/month. Available capacity, applicable site, and project scope are confirmed per inquiry.

Route assessment Purification and scale planning Analytical alignment
Explore manufacturing capabilities
200kg/monthAggregate factory capacity
2U.S. warehouse support pathways
3Core peptide APIs
GlobalB2B supply coordination

From synthesis planning to final-form requirements.

A process overview connects route definition, preparative purification, concentration, and final-form planning. The applicable sequence is defined for each molecule and project.

  1. Peptide synthesis column with resin, reagent bottles, tubing, and stainless process fittingsProcess illustration

    SPPS route definition & assembly

    Sequence, modification strategy, resin, coupling route, and development scale are reviewed against the molecule and project brief.

  2. Side view of a preparative chromatography system and its pipeworkField photograph

    Preparative purification

    Align the separation approach, fraction collection, pooling, and subsequent handling with the product-specific process.

  3. Rotary evaporators arranged in a process roomField photograph

    Concentration and material handling

    Review concentration and material-handling requirements within the selected process route. Pictured: rotary evaporation equipment.

  4. Freeze-dried peptide material, technical packaging, and batch documentation at a lyophilizerProcess illustration

    Final form and batch handoff

    Final form, storage, packaging, batch documents, and the release and dispatch plan are coordinated with the agreed supply scope.

Field photographs show preparative chromatography and rotary evaporation. Synthesis and final-form images are illustrations. Process scope, sequence, and batch results are confirmed per project.

Review the complete process pathway

Connected review

Technical, quality, and supply coordination in one flow.

Technical dialogue

Focused communication around the real requirements of the qualified project.

Evidence planning

Product-, site-, method-, and batch-specific document scope is confirmed.

Supply coordination

Production, eligible inventory, regional routing, and delivery planning in one view.

Global supply

Global Supply. Local Support.

U.S. warehouse support through Los Angeles and New Jersey may be available for eligible inventory. Product eligibility, local availability, release, documents, carrier, destination, and timing remain order-specific.

Eligibility and local availability review Regional dispatch planning
Review regional supply planning
Los Angeles skyline representing the U.S. West regional supply pathway U.S. West

Cold-storage pathway review for eligible West Coast inventory and qualified orders.

Discover more

Los Angeles

Jersey City waterfront and Lower Manhattan representing the New Jersey U.S. East pathway U.S. East

Cold-storage pathway review for eligible East Coast inventory and qualified orders.

Discover more

New Jersey

Main building at the LUMIRABIO operating campus in Fujian, China

About LUMIRABIO

Peptide-Focused.
Technically Coordinated.

From its Fujian operating base, including the Jinjiang manufacturing pathway and the Quanzhou–Xiamen–Jinmen Life & Health Silicon Valley, LUMIRABIO connects R&D, production, analytical review, and supply planning.

Jinjiang manufacturing base in Fujian Synthesis, purification, and analytical testing Laboratory development through kilogram-scale pilot review 200 kg/month aggregate factory capacity
About LUMIRABIO

Technical resources and industry context

Technical Resources &
Industry Insights

Follow the process, analytical, quality, and regional-supply questions that shape the next peptide API sourcing decision.

View all blog and insights

Questions before you begin

Clear Answers.
Better Prepared Discussions.

Review the practical questions that usually arise during early product, documentation, manufacturing, and supply evaluation.

Need a project-specific answer?Include the molecule, intended use, market, specification, quantity, documents, destination, and timing.
View all FAQ topics